Jim Simons Soleno Therapeutics Inc Transaction History

Renaissance Technologies LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.14 - $0.23 $42,270 - $69,444	301,931 Added 121.65%	550,131 $102,000
Q1 2022 May 13, 2022	BUY	$0.22 - $0.47 $41,272 - $88,172	187,600 Added 309.57%	248,200 $55,000
Q4 2021 Feb 11, 2022	BUY	$0.41 - $0.91 $20,582 - $45,682	50,200 Added 482.69%	60,600 $25,000
Q3 2021 Nov 12, 2021	SELL	$0.8 - $1.12 $291,028 - $407,439	-363,785 Reduced 97.22%	10,400 $10,000
Q2 2021 Aug 13, 2021	BUY	$0.97 - $1.32 $362,959 - $493,924	374,185 New	374,185 $427,000
Q3 2020 Nov 13, 2020	SELL	$1.71 - $2.51 $246,682 - $362,090	-144,259 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.77 - $4.23 $49,202 - $117,585	27,798 Added 23.87%	144,259 $320,000
Q1 2020 May 14, 2020	SELL	$1.64 - $3.85 $23,452 - $55,055	-14,300 Reduced 10.94%	116,461 $277,000
Q4 2019 Feb 13, 2020	SELL	$1.35 - $2.95 $34,574 - $75,552	-25,611 Reduced 16.38%	130,761 $384,000
Q3 2019 Nov 13, 2019	BUY	$1.5 - $2.99 $20,200 - $40,266	13,467 Added 9.42%	156,372 $235,000
Q2 2019 Aug 12, 2019	BUY	$1.93 - $2.95 $153,014 - $233,881	79,282 Added 124.61%	142,905 $400,000
Q1 2019 May 14, 2019	BUY	$1.35 - $2.68 $85,891 - $170,509	63,623 New	63,623 $131,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $375M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.